Evidence map›Paper›PMID 40701827›Full record

ArticleBrain pathology (Zurich, Switzerland)2026

Dendritic location of dystrophic neurites in FTLD-TDP type C with annexinopathy.

Allegra Kawles, Antonia Zouridakis, Caroline Nelson, Rachel Keszycki, Grace Minogue, Alyssa Macomber, Pouya Jamshidi, Rudolph J Castellani, Changiz Geula, Tamar Gefen and 1 more

Abstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Allegra KawlesMesulam Institute for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0003-3153-5350
Antonia ZouridakisMesulam Institute for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Caroline NelsonMesulam Institute for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Rachel KeszyckiMesulam Institute for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Grace MinogueMesulam Institute for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Alyssa MacomberMesulam Institute for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Pouya JamshidiMesulam Institute for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0002-2038-8589
Rudolph J CastellaniMesulam Institute for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Changiz GeulaMesulam Institute for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Tamar GefenMesulam Institute for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
M-Marsel MesulamMesulam Institute for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Funding

Neuropathology CoreP30AG013854 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI VASSAR, ROBERT J · 1996 to 2020
$28.9M
Research Education Core FP30AG072977 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ROBERT J VASSAR · 2021 to 2026
$26.3M
ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIAR01AG077444 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MAREK-MARSEL M MESULAM, EMILY J ROGALSKI · 2022 to 2026
$10.4M
PREDOCTORAL AND POSTDOCTORAL TRAINING PROGRAM IN AGING AND DEMENTIAT32AG020506 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ROBERT J VASSAR, SANDRA WEINTRAUB · 2002 to 2026
$9.9M
Language in Primary Progressive AphasiaR01DC008552 · NIDCD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MESULAM, MAREK-MARSEL M · 2007 to 2021
$8.5M
Determinants of Neurodegenerative Decline in Primary Progressive AphasiaR01NS075075 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ROGALSKI, EMILY J · 2012 to 2016
$1.7M
Anatomic, Pathologic, and Molecular Signatures of FTLD-TDP type CR01AG091388 · NIA · NORTHWESTERN UNIVERSITY · PI CHANGIZ GEULA, Tamar D Gefen · 2025 to 2026
$1.6M
Clinical, Anatomic, and Pathologic Spread of Semantic Language Impairment in the Type C Variant of Frontotemporal Lobar Degeneration due to TDP-43 (TDP-C)F31AG094137 · NIA · NORTHWESTERN UNIVERSITY · PI KAWLES, ALLEGRA · 2025 to 2025
$50k
Karen Toffler Charitable TrustNational Science Foundation DGE-1842165NIA NIH HHS F31 AG094137NIA NIH HHS P30 AG013854NIA NIH HHS P30 AG072977NIA NIH HHS R01 AG077444NIA NIH HHS R01 AG091388NIA NIH HHS T32 AG020506NIDCD NIH HHS R01 DC008552NIDCD NIH HHS R01 NS075075NINDS NIH HHS R01 DC008552NINDS NIH HHS R01 NS075075
6 · The paper itself

Abstract

The type C variant (TDP-C) of FTLD-TDP exhibits unique features, not shared by types A and B, namely the invariable and frequently asymmetric predilection for the anterior temporal lobes (ATL). Depending on the direction of hemispheric asymmetry, the associated clinical features include word comprehension impairment, associative agnosia, and behavioral abnormalities. Current research on TDP-C aims to explore the factors that underlie the selective targeting of the ATL and, more specifically, the cellular details that undermine the behavioral and cognitive functions of this region. Abnormal TDP-C neurites have recently been shown to represent heterodimers with annexin A11 (ANXA11). This feature, not shared by TDP-A or -B, may explain the unique predilection of TDP-C for the ATL. To further explore the subcellular distribution of the pathology, paraffin-embedded sections were stained using fluorescent antibodies for the dendritic marker MAP2 and phosphorylated TDP-43 (pTDP) or ANXA11. Results indicated that approximately half of pTDP/ANXA11 neurites co-localized with MAP2. The actual overlap during life may be much higher but decreased at autopsy through dendritic loss due to prolonged neurodegeneration. The potentially selective and progressive dendritic pathology of TDP-C, quite unique among neurodegenerative entities, may underlie the distinctive perturbation of cortical integrative computations.

Indexed as

AnnexinsDendritesFrontotemporal Lobar DegenerationNeuritesAgedAged, 80 and overDNA-Binding ProteinsFemaleHumansMaleMiddle AgedTemporal LobeAnnexinsDNA-Binding ProteinsTARDBP protein, humandystrophic neuritesFTLD‐TDPFTLD‐TDP‐CTDP‐43TDP type C

Identifiers

PMID40701827
PMCPMC12695699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.